A new hope or a new nightmare? Concerned about the conflicted data
Authors:
- Peng-Hui WangPeng-Hui Wang
- Chih-Ping ChenCCChih-Ping Chen
Open Access
- 1 September 2021
- journal article
- editorial
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 60 (5) , 799-800
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Low-level mosaicism for trisomy 16 at amniocentesis in a pregnancy associated with intrauterine growth restriction and a favorable outcomeTaiwanese Journal of Obstetrics and Gynecology, 2021
- Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth RestrictionJAMA Network Open, 2020
- Notice of Retraction: “Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial” (Maher MA, Sayyed TM, and Elkhouly N)Obstetrics & Gynecology, 2020
- Sildenafil therapy in early‐onset fetal growth restriction: waiting for the individual patient data meta‐analysisBJOG: An International Journal of Obstetrics & Gynaecology, 2019
- STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early‐onset fetal growth restrictionBJOG: An International Journal of Obstetrics & Gynaecology, 2019
- Fetal Medicine Foundation reference ranges for umbilical artery and middle cerebral artery pulsatility index and cerebroplacental ratioUltrasound in Obstetrics & Gynecology, 2019
- RETRACTED: Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trialTaiwanese Journal of Obstetrics and Gynecology, 2018
- Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trialThe Lancet Child & Adolescent Health, 2018
- The STRIDER trial: one step forward, one step backThe Lancet Child & Adolescent Health, 2017
- Readers' comment is important for the journalTaiwanese Journal of Obstetrics and Gynecology, 2015